TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA...

Annals of Oncology 2020 / 09 Vol. 31

TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA damage response alterations (DDRalt) and metastatic castration-resistant prostate cancer (mCRPC): Exploration of DDRalt germline/somatic origin

Mehra, N., Fizazi, K., Laird, A.D., Barthélémy, P., Delva, R., Dorff, T., Maruzzo, M., Stirling, A., Machiels, J-P., Dumez, H., Renard, V., Albacker, L.A., Hopkins, J., Chen, H-C., Mata, M., Di Sant
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.259
Date:
September, 2020
File:
PDF, 98 KB
2020
Conversion to is in progress
Conversion to is failed